We are committed to providing the best healthcare services tailored to your needs. With a team of experienced medical professionals and state-of-the-art technology,
According to Towards Healthcare Study, Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical innovator developing CD19 and CD22-targeted ARTEMIS® T-cell therapies for autoimmune and oncological diseases, has announced outstanding results f...
Read Full Report ⟶The generative AI in healthcare market size is anticipated to grow from USD 2.65 billion in 2025 to USD 39.68 billion by 2034, with a compound annual growth rate (CAGR) of 35.1% during the forecast period from 2025 to 2034, because of the potential...
Read Full Report ⟶The global Ambulatory Surgical Center market was valued at USD 105.58 billion in 2024 and is projected to reach USD 183.1 billion by 2034, expanding at a CAGR of 5.66% (2025–2034)—driven by rising surgical volumes, growing out...
Read Full Report ⟶The global genomics market size is projected to reach USD 171.41 billion by 2034, growing from USD 44.72 billion in 2025 at a CAGR of 16.1%, driven by technological advancements, AI integration, and the rising demand for personali...
Read Full Report ⟶The U.S. dental services market is projected to reach USD 172.6 billion in 2025, with a CAGR of 4.4% from 2025 to 2034, growing to USD 254.7 billion by 2034. The market is being driven by increasing disposable incomes, rising awareness of oral health...
Read Full Report ⟶The global radiotherapy market is valued at USD 7.88 billion in 2024 and is projected to grow to USD 8.44 billion in 2025, reaching USD 15.63 billion by 2034, with a steady CAGR of 7.09% from 2025 to 2034. The market's expansion is driv...
Read Full Report ⟶We are committed to providing the best healthcare services tailored to your needs We are committed to providing the best healthcare services tailored
